| Literature DB >> 33869264 |
Sui Xiao1, Jingyuan Huang2, Yahui Huang3, Huiqing Lai4, Yi Zheng4, Dahua Liang4, Hang Xiao2, Xu Zhang1.
Abstract
Ganpu tea is a novel type of tea beverage with unique and pleasant flavor that encases Pu-erh tea leaves within an intact mandarin peel. However, to date, no holistic and detail studies on its chemical composition and biological activities have been reported yet. In the present study, by applying UPLC-Q-TOF and UPLC-MS technology, we systematically identified and analyzed 104 water-soluble compounds of Ganpu tea and their variation trend during the sun-drying processing. The results showed that the generation of pigments and gallic acid coincided with a dramatic decrease in catechin content, and a significant increase in alkaloid and flavonoid contents. The conversion of these compounds can contribute to the improvement of sensory attributes of Ganpu tea and maybe indispensable to its unique flavor. Moreover, the mice given orally with high dose of Ganpu tea (0.4 g/kg) showed a significantly reduced immobility duration as compared to that of the negative control group (p < 0.01) both in the forced swimming test and tail suspension test. Together, these results indicate that the sun-drying processing was indispensable to the formation of the unique flavor for Ganpu tea. Multiple types of compounds of Ganpu tea may collectively provide the synergistic attributes to its antidepressant-like properties.Entities:
Keywords: Ganpu tea; antidepressant-like properties; flavor; health functions; sun-drying processing
Year: 2021 PMID: 33869264 PMCID: PMC8044837 DOI: 10.3389/fnut.2021.647537
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Sample information sheet.
| S1 | Pu-erh raw tea | Harvested from Yunnan | 2016.12 |
| S2 | Mandarin peel | Harvested from Xinhui, Guangdong | 2016.12 |
| S3 | Ganpu tea | Made from S1 and S2 | 2016.12 |
| S4 | Ganpu tea 0 day | 0 day of the full sun-drying processing | 2018.09 |
| S5 | Ganpu tea 3 day | 3 day of the full sun-drying processing | 2018.09 |
| S6 | Ganpu tea 9 day | 9 day of the full sun-drying processing | 2018.09 |
| S7 | Ganpu tea 15 day | 15 day of the full sun-drying processing | 2018.09 |
Figure 1Comparisons of the chemical compositions among Pu-erh raw tea, mandarin peel, and Ganpu tea by TIC in positive ion mode (A), TIC in negative ion mode (B), and UV chromatogram (C), respectively. In our previous study, we investigated the source and conversion of aromatic substances of Ganpu tea. The fruity sweet aromas compounds of Ganpu tea were consisted of the main volatile components of Pu-erh raw tea and mandarin peel, in addition to the newly generated compounds during the sun-drying processing (14). Based on the data obtained from the present study, we could draw a similar conclusion that the water-soluble substances of Ganpu tea were not just a simple combination of the compounds of Pu-erh raw tea and mandarin peel. Rather, the water-soluble substances of Ganpu tea were mainly attributed to the development and transformation of the precursor ingredients that it contains and to several newly generated substances during the sun-drying processing. The final formation of the flavor of Ganpu tea may be closely related to the production and conversion of these water-soluble substances. Further researches are necessary to investigate the contribution of these compounds to the flavor characteristic of Ganpu tea.
List of the identified components in tested samples.
| 1 | Theanine | 1.7 | [M+H]+ | 175.1082 | 158, 129 | C7H14N2O3 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 2 | Leucine | 2.1 | [M+H]+ | 132.1012 | 132, 86 | C6H13NO2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 3 | Phenylalanine | 3.28 | [M+H]+ | 166.0863 | 120 | C9H11NO2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 4 | Tryptophan | 6.3 | [M+H]+ | 205.0974 | 143, 118 | C11H12N2O2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 5 | Tyrosine | 3.05 | [M+H]+ | 182.0808 | 165, 136 | C9H11NO3 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 6 | Pyroglutamic acid | 2.6 | [M+H]+ | 130.0501 | _ | C5H7NO3 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 7 | * Isoleucine | 2.3 | [M+H]+ | 132.1013 | 86 | C6H13NO2 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
| 8 | * Threonine | 3.2 | [M+H]+ | 120.0650 | _ | C4H9NO3 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
| 9 | * Arginine | 1.45 | [M+H]+ | 175.1120 | 158, 129 | C6H14N4O2 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
| 10 | * Glutamine | 8.25 | [M+H]+ | 147.0758 | 119, 91 | C5H10N2O3 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
| 11 | Gallocatechin (GC) | 3.35 | [M+H]+ | 307.0813 | _ | C15H14O7 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 12 | (-)-Epigallocatechin (EGC) | 7.00 | [M+H]+ | 307.0814 | 223, 163 | C15H14O7 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 13 | Catechin (C) | 8.7 | [M+H]+ | 291.0869 | _ | C15H14O6 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 14 | Epicatechin (EC) | 19.4 | [M+H]+ | 291.0863 | 165, 139 | C15H14O6 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 15 | Epigallocatechin gallate (EGCG) | 19.8 | [M+H]+ | 459.0922 | 289, 139 | C22H18O11 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 16 | Gallocatechin gallate (GCG) | 24.0 | [M+H]+ | 459.0924 | 289, 139 | C22H18O11 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 17 | Epicatechin gallate (ECG) | 31.3 | [M+H]+ | 443.0972 | 273, 139 | C22H18O10 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 18 | Catechin gallate (CG) | 32.6 | [M+H]+ | 443.0973 | _ | C22H18O10 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 19 | (-)-EGCG-3″-O-ME | 22.6 | [M-H]- | 471.0920 | _ | C23H20O11 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 20 | Epiafzelechin | 3.00 | [M+H]+ | 275.0919 | _ | C15H14O5 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 21 | Epiafzelechin-3-O-gallate | 37.2 | [M-H]- | 424.0795 | 273 | C22H17O9 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 22 | Gallocatechin-(4a-8)-catechin-3-O-gallate | 20.7 | [M-H]- | 745.1399 | 457, 423 | C37H30O17 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 23 | Digallocatechin-catechin | 25.9 | [M-H]- | 897.1869 | 423 | C45H38O20 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 24 | *Catechin-4a-epicatechin-3-O-gallate | 24.5 | [M+H]+ | 731.1608 | 427, 289 | C37H30O16 | _ | _ | ✓ | _ | ✓ | ✓ | ✓ |
| 25 | Trigalloylglucose | 28.25 | [M-H]- | 635.0880 | 423, 169 | C27H24O18 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 26 | *Catechin-4a-epicatechin 3'-o-gallate | 26.5 | [M+H]+ | 731.1608 | 427, 289 | C37H30O16 | _ | _ | ✓ | _ | ✓ | ✓ | ✓ |
| 27 | Theasinesnsins A | 32.00 | [M+H]+ | 611.1395 | 465,303 | C30H26O14 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 28 | Theasinesnsins B | 33.1 | [M+H]+ | 611.1396 | 465, 303 | C30H26O14 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 29 | Caffeine | 11.0 | [M+H]+ | 195.0877 | 157 | C8H10N4O2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 30 | Theobromine | 3.45 | [M+H]+ | 181.0721 | 138, 108 | C7H8N4O2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 31 | Theophylline | 5.3 | [M+H]+ | 181.0718 | _ | C7H8N4O2 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 32 | Theaflavin | 30.0 | [M-H]- | 563.1190 | _ | C29H24O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 33 | *Procyanidin B1 | 15.17 | [M+H]+ | 579.1497 | 409, 289 | C30H26O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 34 | *Procyanidin B2 | 15.26 | [M+H]+ | 579.1497 | 409, 289 | C30H26O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 35 | *Procyanidin B3 | 15.7 | [M+H]+ | 579.1495 | 409, 127 | C30H26O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 36 | *Procyanidin B4 | 15.76 | [M+H]+ | 579.1497 | 409, 289 | C30H26O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 37 | Procyanidin B1 3-O-gallate | 24.5 | [M+H]+ | 731.1608 | 427, 289 | C37H30O16 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 38 | Procyanidin B2 3-O-gallate | 26.5 | [M+H]+ | 731.1608 | 427, 289 | C37H30O16 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 39 | Rutin | 41.0 | [M+H]+ | 611.1606 | 465, 303 | C27H30O16 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 40 | Kaempferol | 37.5 | [M+H]+ | 287.0552 | _ | C15H10O6 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 41 | *Kaempferol-3-O-glucoside | 35.91 | [M-H]- | 447.0929 | 284, 255 | C21H20O11 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 42 | *Kaempferol-3-O-galactoside | 37.56 | [M-H]- | 447.0925 | 284, 255 | C21H20O11 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 43 | *Kaempferol-3- O-rutinoside | 37.1 | [M-H]- | 593.1509 | _ | C27H30O15 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 44 | *Kaempferol-3- O-glucosylrutinoside | 35.6 | [M-H]- | 755.2031 | _ | C33H40O20 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 45 | *Myricetin-3-O-glucoside | 27.2 | [M-H]- | 479.0824 | _ | C21H20O13 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 46 | ** Myricetin−3- locust glycoside | 28.1 | [M+H]+ | 625.1036 | _ | C26H24O18 | _ | _ | ✓ | _ | ✓ | ✓ | ✓ |
| 47 | **Myricetin-3-O-galactoside | 28.05 | [M-H]- | 479.0827 | _ | C21H20O13 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 48 | Quercetin | 30.3 | [M+H]+ | 303.0500 | 287, 257 | C15H10O7 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 49 | ** Quercetin−3-o- rhamnoside galactoside | 39.35 | [M+H]+ | 611.1250 | 303 | C26H26O17 | _ | _ | ✓ | _ | ✓ | ✓ | ✓ |
| 50 | *Quercetin | 32.4 | [M-H]- | 463.0877 | 300, 271 | C21H20O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 51 | *Quercetin | 33.5 | [M-H]- | 463.0878 | 300, 271 | C21H20O12 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 52 | *Quercetin−3- O-glucosylrutinoside | 31.85 | [M+H]+ | 773.2136 | 303, 465 | C33H40O21 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 53 | * Vitexin | 49.5 | [M+H]+ | 433.1129 | 395 | C21H20O10 | _ | _ | ✓ | _ | ✓ | ✓ | ✓ |
| 54 | Gallic acid | 2.25 | [M-H]- | 169.0142 | 125 | C7H6O5 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 55 | Quinic acid | 1.3 | [M-H]- | 191.0560 | 111, 87 | C7H12O6 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 56 | Caffeic acid | 2.21 | [M+H]+ | 181.0500 | 157 | C9H8O4 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 57 | Malic acid | 1.4 | [M-H]- | 133.0137 | 75 | C4H6O5 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 58 | Ascorbic acid | 1.9 | [M-H]- | 175.0240 | 115, 85 | C6H8O6 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 59 | Caffeoylmalic acid | 3.3 | [M-H]- | 295.0442 | 191, 113 | C13H12O8 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 60 | *3-O-galloylquinic acid | 2.15 | [M-H]- | 343.0662 | 191, 169 | C14H16O10 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 61 | *5-O-galloylquinic acid | 2.48 | [M-H]- | 343.0664 | 191, 169 | C14H16O10 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 62 | Chlorogenic acid | 5.0 | [M-H]- | 353.0870 | 191 | C16H18O9 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 63 | *1-Caffeoylquinic acid | 10.00 | [M-H]- | 353.0871 | 191 | C16H18O9 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 64 | *3-Caffeoylquinic acid | 10.09 | [M-H]- | 353.0869 | 291, 191 | C16H18O9 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 65 | *1-p-Coumaroylquinic acid | 16.01 | [M-H]- | 337.0915 | 305, 163 | C16H18O8 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 66 | *3-p-Coumaroylquinic acid | 16.3 | [M-H]- | 337.0917 | 305, 163 | C16H18O8 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 67 | *4-p-Coumaroylquinic acid | 16.87 | [M-H]- | 337.0918 | 305, 163 | C16H18O8 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 68 | *5-p-Coumaroylquinic acid | 16.92 | [M-H]- | 337.0918 | 305, 163 | C16H18O8 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 69 | Galloylglucose | 45.5 | [M-H]- | 331.0662 | 169 | C13H16O10 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 70 | 1,2,6-Trigalloylglucose | 28.2 | [M-H]- | 635.0882 | 465, 313 | C27H24O18 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 71 | 3,6-Digalloylglucose | 9.9 | [M-H]- | 483.0773 | 169 | C20H20O14 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 72 | Strictinin | 11.8 | [M-H]- | 633.0725 | 301, 275 | C27H22O18 | ✓ | _ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 73 | Synephrine | 1.66 | [M+H]+ | 168.1012 | 150, 135 | C9H13NO2 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 74 | Lucenin-2 | 3.691 | [M+H]+ | 611.1609 | 575, 473 | C27H30O16 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 75 | Naringenin | 23 | [M+H]+ | 273.0757 | 274, 202 | C15H12O5 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 76 | Vicenin-2 | 37 | [M+H]+ | 595.1658 | 457, 409 | C27H30O15 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 77 | Diosmetin-6, 8-di-C-glucoside | 28.1 | [M+H]+ | 625.1762 | 607, 589 | C28H32O16 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 78 | Naringin | 37.75 | [M+H]+ | 581.1864 | _ | C27H32O14 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 79 | Chysoeriol-6, 8-di-C-glucoside | 29.2 | [M+H]+ | 625.1766 | 409, 355 | C28H32O16 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 80 | Diosmetin-6-C-glucoside | 35.8 | [M+H]+ | 463.1236 | 367, 343 | C22H22O11 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 81 | Narirutin | 37.7 | [M-H]- | 579.1711 | 271 | C27H32O14 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 82 | Rhoifolin | 12.0 | [M+H]+ | 579.1709 | 433, 271 | C27H30O14 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 83 | Diosmin | 39.2 | [M+H]+ | 609.1816 | 463, 301 | C28H32O15 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 84 | Hesperidin | 39.35 | [M-H]- | 609.1818 | 343, 301 | C28H34O15 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 85 | Poncirin | 26.1 | [M+H]+ | 595.2023 | 463, 379 | C28H34O14 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 86 | Citrusin III | 43.8 | [M+H]+ | 728.3982 | 700, 587 | C36H53N7O9 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 87 | Melitidin | 44.5 | [M+H]+ | 725.2293 | 419, 404 | C33H40O18 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 88 | Monohydroxy-tetramethoxyflavone | 48.95 | [M+H]+ | 359.1125 | 329, 301 | C19H18O7 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 89 | Pentamethoxyflavanone | 50.15 | [M+H]+ | 375.1441 | 211, 196 | C20H22O7 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 90 | Monohydroxy-pentamethoxyflavone | 51.2 | [M+H]+ | 389.1231 | 374, 359 | C20H20O8 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 91 | Isosinensetin | 45.6 | [M+H]+ | 373.1284 | 343, 153 | C20H20O7 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 92 | Sinensetin | 47 | [M+H]+ | 373.1283 | 343, 153 | C20H20O7 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 93 | Tetramethyl-O-isoscutellarein | 47.2 | [M+H]+ | 343.1176 | 328, 313 | C19H18O6 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 94 | Limonin | 43 | [M+H]+ | 471.2015 | 425, 397 | C26H30O8 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 95 | Nobiletin | 48.5 | [M+H]+ | 403.1386 | 373, 211 | C21H22O8 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 96 | Tetramethyl-O-scutellarein | 48.6 | [M+H]+ | 343.1175 | 327, 313 | C19H18O6 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 97 | 3, 5, 6, 7, 8, 3′, 4′-Heptamethoxyflavone | 49.5 | [M+H]+ | 433.1496 | 403, 388 | C22H24O9 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 98 | Tangeretin | 50.2 | [M+H]+ | 373.1285 | 358, 343 | C20H20O7 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 99 | 5-Hydroxy-6, 7, 8, 3′, 4′-pentamethoxyflavone | 46.1 | [M+H]+ | 389.1231 | _ | C20H20O8 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 100 | 5-Hydroxy-4′- methoxy flavone-7-o-glycoside | 37.5 | [M+H]+ | 449.1440 | 287 | C22H24O10 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 101 | *4H-1-Benzopyran-4-one,2,3-dihydro-5,6,7,8-tetramethoxy-2-[4-(phenylmethoxy)phenyl]- | 44.45 | [M+H]+ | 725.1870 | _ | C39H32O14 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
| 102 | 4H-1-Benzopyran-4-one,6,8-di-b-Dglucopyranosyl-5,7-di-hydroxy-2-(4-hydroxy-3-me-thoxyphenyl)- | 28.1 | [M+H]+ | 625.1765 | _ | C28H32O16 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 103 | 4H-1-Benzopyran-4-one,6,8-di-b-Dglucopyranosyl-5,7-di-hydroxy-2-(3-hydroxy-4-me-thoxyphenyl)- | 29.3 | [M+H]+ | 625.1764 | _ | C28H32O16 | _ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 104 | *4H-1-Benzopyran-4-one, 2-phenyl-,dihyroxy trimethoxy deriv | 38.79 | [M+H]+ | 343.0662 | 191 | C14H14O10 | _ | _ | ✓ | _ | _ | ✓ | ✓ |
Compounds labeled with asterisk (*) were newly generated during the sun-drying processing. Compounds labeled with star (*) means putative identification. “✓” means detected in this sample, and “_” means not detected in this sample.
Figure 2Flavor substances of Ganpu tea were identified by UPLC-Q-TOF system in different categories, including ten amino acids (A), 18 catechins and their derivatives (B), three alkaloids and seven pigments (C), 15 flavonoids and their derivatives (D), 19 organic acids and their derivatives (E), and 32 water-soluble compounds of mandarin peel (F), respectively.
Analysis of biochemical components of Ganpu tea samples with different durations of the full sun-drying processing.
| Moisture | 24.16 ± 1.38a | 21.23 ± 1.04b | 12.17 ± 0.76c | 5.04 ± 0.98d |
| Water extract | 30.04 ± 2.15d | 31.72 ± 2.23cd | 33.58 ± 2.02b | 34.86 ± 1.93ab |
| Total free amino acids | 2.37± 0.32a | 2.03 ± 0.52b | 2.33 ± 0.29a | 2.43 ± 0.20a |
| Tea polyphenols | 18.45 ± 1.02a | 16.77 ± 0.15b | 14.10 ± 1.13c | 12.12 ± 1.42d |
| Theaflavins | 0.24 ± 0.13a | 0.15 ± 0.46b | 0.13 ± 0.65bc | 0.10 ± 0.02c |
| Thearubigins | 1.36 ± 0.10c | 1.49 ± 0.13b | 1.50 ± 0.11b | 1.85 ± 0.12a |
| Theabrownine | 1.25 ± 0.17c | 1.26 ± 0.03c | 1.34 ± 0.20b | 1.77 ± 0.21a |
Differences between samples were analyzed by Duncan's test. In each horizontal line, the mean ± SD values bearing different letters differ significantly (p < 0.05).
Figure 3Heatmap analysis of potential flavor compounds from Ganpu tea.
Figure 4Aroma and flavor profiles of Ganpu tea samples with different durations of sun-drying processing. The statistical analyses were performed using ANOVA, followed by LSD test (*p < 0.05, **p < 0.01).
Figure 5Effects of Ganpu tea on the immobility duration of mice in the behavioral tests. (A) FST, and (B) TST. Data are expressed as mean ± SD (n = 12 mice per group). NC, normal control group; PC, clomipramine hydrochloride tablets group (0.02 g/kg). The statistical analyses were performed using ANOVA, followed by LSD test, *p < 0.05, **p < 0.01 as compared with that of the NC group.